Filter
105
Filtered Results: 105
Text search:
Fabian,
D.
Featured
Recommendations
7
New Publications
23
Language
Document type
No document type
41
Studies & Reports
30
Guidelines
29
Strategic & Response Plan
3
Manuals
2
Countries / Regions
Latin America and the Carribbean
12
Brazil
9
Global
5
Western and Central Europe
4
Argentina
4
Africa
3
Asia
2
Venezuela
2
Germany
2
Paraguay
2
Uganda
2
Russia
2
Colombia
1
Kenya
1
Ukraine
1
Benin
1
Syria
1
Nigeria
1
Peru
1
Malawi
1
Zimbabwe
1
Philippines
1
West and Central Africa
1
Middle East and North Africa
1
South Africa
1
Papua New Guinea
1
Sudan
1
Yemen
1
India
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Guidelines
15
COVID-19
13
Studies & Reports
7
Non-communicable Diseases
5
Vector Control
4
Sexual Violence
4
Violence against Children
4
Disease Prevention & Control
4
Countries
3
Policies
3
Hepatitis
2
Chagas
2
Community Health
2
Leishmaniasis
2
Zika
1
Child Health
1
Disaster Preparedness
1
Cancer
1
Palliative Care
1
Snakebites
1
Pediatrics
1
Hemorrhagic Fever
1
Demograhic Health Surveys DHS
1
Policies & Guidelines HIV & TB
1
Drugs & Medical Equipment
1
Women & Child Health
1
Humanitarian Crisis
1
Other
1
Nutrition
1
Dengue
1
Age & Elderly
1
Malaria
1
Reproductive Health
1
Pharmacy & Technologies
1
Toolboxes
Country specific documents
7
Clinical Guidelines
6
Assessment & Studies
5
IACAPAP International Association for Child and Adolescent Psychiatry and Allied Professions
5
Children/Adolescents Mental Disorders
5
Attention deficit hyperactivity disorder (ADHD)
3
Medical & Community Masks
3
Vector control
3
Studies & Reports
3
Gynaecology / Obstetrics
2
Context & Facts
2
PPE Personel Protective Equipment
2
Chagas
2
Overview, Studies & Reports
2
Prevention & Strategies
2
Alzheimer's Disease & Dementia
2
Overview & Statistics
2
Reports & Studies
2
Risk Communication & Community Engagement
2
Violence & Child Trafficking
1
Sexual and gender-based violence (SGBV)
1
ART Drug Resistance
1
Surveillance
1
Surveillance
1
Country specific
1
Prevention & Control
1
Children & Adolescents
1
Pediatrics
1
Dengue
1
Refugee
1
Public Health
1
Surveillance
1
TB & Other Vulnerable Populations
1
Microcephaly
1
International
1
Treatment Guidelines
1
Essential List
1
Context & Facts, Travel Advice
1
For Parents & Children
1
Clinical Guidelines
1
Child Protection
1
LGBTI*
1
General
1
Immunization Guidelines
1
Non-pharmaceutical interventions (NPIs)
1
Long COVID/ Post-COVID Syndrome
1
Moderna
1
Biontech/Pfizer Comirnaty
1
Vaxzevria (Astra Zeneca)
1
Johnson & Johnson
1
Stress
1
Community Health Workers CHW
1
Nurses
1
Palliative Care
1
Booster Doses
1
Climate Change General
1
Clean air
1
Essential Medicines & Devices Lists
1
Pediatrics
1
Land-system change
1
Agriculture incl. animal husbandry
1
Argentina
1
Heat
1
Leishmaniasis
1
Studies & Reports
1
Studies & Reports
1
Snakebite envenoming
1
Statistics & Facts
1
Asia and Pacific
1
National Emergency Response Plans
1
Policy
1
TB/HIV Global
1
Latin America & the Carribean
1
Chikungunya Prevention & Control
1
Zika Prevention & Control
1
Reports & Studies Children HIV
1
Epidemiology
1
Case Definitions
1
Public Health
1
Preparedness & Prevention
1
Guidelines on hepatitis B and C testing
recommended
Testing and diagnosis of hepatitis B (HBV) and C (HCV) infection is the gateway for access to both prevention and treatment services, and is a crucial component of an effective response to the hepatitis epidemic. Early identification of persons with chronic HBV or HCV infection enables them to recei...
TNew data from the World Health Organization reveal that the COVID-19 pandemic has disrupted malaria services, leading to a marked increase in cases and deaths.
According to WHO’s latest World malaria report, there were an estimated 241 million malaria cases and 627 000 malaria deaths worldwide i...
The goal of this Global Action Plan is to articulate synergistic actions that will be required to prevent HIVDR from undermining efforts to achieve global targets on health and HIV, and to provide the most effective treatment to all people living with HIV including adults, key populations, pregnant ...
Identified through evaluation of the response to pandemic (H1N1) 2009
The 2012 NDRMP lays out the Disaster Risk Management (DRM) architecture of the country and provides guidance for DRM intervention at all levels. However, implementation has been slow and resource challenges exist throughout the government.
The PNG government’s policy and institutional framework...
The PNG government’s policy and institutional framework...
as of 12:00 AM, 17 September 2018 - 6:00 AM, 17 September 2018
Molecular methods for antimicrobial resistance (AMR)diagnostics to enhance the Global Antimicrobial Resistance Surveillance System
Intensive Care Med (2009) 35:9–29DOI 10.1007/s00134-008-1336-9
Although thousands of papers have been devoted tohospital-acquired pneumonia (HAP), many controversiesremain, and management of HAP is probably often sub-optimal. Several reviews or guidelines have been pub-lished rec...
Применение масок в условиях COVID-19
recommended
Временные руководящие принципы 1 декабря 2020 года. Обновленная версия
В этом документе представлено обновленное руководство по использованию масок в медицинских ...
Bisher hat die STIKO empfohlen, dass alle im Ausland mit einem nicht in der EU zugelassenen Impfstoff geimpften Personen eine erneute Impfserie mit einem in der EU zugelassenen Impfstoff erhalten sollen. Ziel der im Epidemiologischen Bulletin 13/2022 veröffentlichten aktualisierten COVID-19-Impfemp...
Journal of Social Work in Developing Societies 13
Vol. 2(1): 13-25 , June 2020
Addressing comorbidities and risk factors for TB is a crucial component of Pillar one of the End TB Strategy, which focuses on integrated patient-centred care and prevention, including action on TB and comorbidities. The Framework for collaborative action on TB and comorbidities aims to support coun...
PLoS Neglected Tropical diseases August 16, 2021 https://doi.org/10.1371/journal.pntd.0009697
Chagas disease, also known as American trypanosomiasis, is a neglected tropical disease transmitted by triatomine insects, first identified in 1909. Chagas disease affects approximately 6–7 million peop...
Population movements have turned Chagas disease (CD) into a global public health problem. Despite the successful implementation of subregional initiatives to control vectorial and transfusional Trypanosoma cruzi transmission in Latin American settings where the disease is endemic, congenital CD (cCD...
Chagas disease (CD), caused by the parasite Trypanosoma cruzi, affects ~6–7 million people worldwide. Significant limitations still exist in our understanding of CD. Harnessing individual participant data (IPD) from studies could support more in-depth analyses to address the many outstanding resea...
As of 12 December 2022, over 645 million people worldwide have been diagnosed with COVID-19, with over 6.6 million deaths (4).
The Omicron variant, which emerged in late November 2021, and its subvariants, are now the dominant circulating viruses, contributing to the ongoing surge in several countr...
This publication describes the first WHO public-benefit Target Product Profiles (TPPs) for snakebite antivenoms. It focuses on antivenoms for treatment of snakebite envenoming in sub-Saharan Africa. Four TPPs are described in the document:
Broad spectrum Pan-African polyvalent antivenoms: products ...
BACKGROUND. Asthma is a heterogeneous condition characterised by chronic inflammation and variable expiratory airflow limitation, as well as airway reversibility. The burden of asthma in children is increasing in low- and middle-income countries and remains under-recognised and poorly managed.
OBJE...
